Famotidine 40mg/5mL; pwd for reconstitution; cherry-banana-mint flavor. Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity ...

Famotidine is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Famotidine ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

Duloxetine (as HCl) 20mg, 30mg, 40mg, 60mg; del-rel caps ... History of seizure disorders, drug abuse. Angle-closure glaucoma. Decreased GI motility. Cardiac disease. Diabetes.

It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class ... The maximum recommended dose is 40 mg/kg. An adult ...

Learn more› By Roderick Scott and Ryan Whitwam After a new round of testing, we’ve added the 2024 Amazon Fire HD 8 tablet as our budget pick and added Samsung’s Galaxy Tab S10+ to the ...

Tablets may not be the hot new thing in 2024, but they're still excellent machines for streaming movies, playing games, or getting work done on the go. And while it seems like the best iPads ...

Tired of squinting at your phone, even though it's one of the best? A tablet might be the perfect solution. But with a dizzying array of options available, finding the right one can be tough.

This is not meant to be a complete dosage guide. Duodenal (Intestinal) Ulcer 20 mg once daily Four weeks; can repeat four weeks if needed Gastric (Stomach) Ulcer 40 mg once daily Four to eight weeks ...

IVP over 2 min Famotidine Merck 0181K 20 mg (2 mg/mL) IVP over 5 min Fentanyl Abbott 58442DK 25 µg (0.05 mg/mL) IVP over 2 min Furosemide American Regent 0078 40 mg (10 mg/mL) IVP over 2 min ...

Learn more› By Roderick Scott, Dave Gershgorn and Nick Guy Apple just announced its new $500 iPad mini tablet. We plan to test it soon, and you can read more details in our What to look forward ...